healthy adult participants
Conditions
Interventions
Ocular administration of SJP-0170 or control drug and blood collection
Sponsors
Omatsu Kazunori
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: - Healthy Japanese aged 18 to 35 years (inclusive) at the time of informed consent. - Principal or sub investigator determined the participant's eligibility for enrollment into the study. - Meet the other protocol-specified inclusion criteria
Exclusion criteria
Exclusion criteria: - Clinically diagnosed any diseases whether under treatment or not. - History of serious systemic/psychiatric disease - Positive for either HBs antigen, syphilis seroreaction, HCV antibody, or HIV antigen/antibody - Intake of caffeines- or alcohol-containing beverages during the period specified in protocol, or use of nicotine-containing product during the period specified in protocol - History of any ocular surgery or traumatic eye injuries which is ineligible to participate the study - History of any drug-induced allergy - Use of any medications during the period specified in protocol. - History of participation in other clinical studies and administered any drugs during the period specified in protocol or be scheduled to participate in other clinical studies during this study. - Requiring use of contact lenses or scheduled to undergo any treatment which deemed to be affected the clinical assessment of investigational product by PI/SI during the period specified in protocol. - Pregnant, possibly pregnant or breast-feeding. Desire for childbearing during the study. Disagree to adhere to practice adequate contraception or no sperm donation during the study. - Have judged inappropriate to participate in the study by investigator. - Meet the other protocol-specified exclusion criteria
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pharmacokinetics and safety (adverse events, etc.) | — |
Contacts
Public Contactdivision Clinical
Senju Pharmaceutical Co., Ltd.
Outcome results
None listed